DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM
Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initi...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
2002 |
|---|
| Umfang: |
19 |
|---|
| Reproduktion: |
Annual Reviews Electronic Back Volume Collection 1932-2005ff |
|---|---|
| Übergeordnetes Werk: |
in: Annual review of medicine - Palo Alto, Calif. : Annual Reviews, 1950, 53(2002), Seite 15-33 |
| Übergeordnetes Werk: |
volume:53 ; year:2002 ; pages:15-33 ; extent:19 |
| Links: |
|---|
| Katalog-ID: |
NLEJ164129421 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ164129421 | ||
| 003 | DE-627 | ||
| 005 | 20230506101902.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 070207s2002 xx |||||o 00| ||und c | ||
| 035 | |a (DE-627)NLEJ164129421 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 245 | 1 | 0 | |a DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM |
| 264 | 1 | |c 2002 | |
| 300 | |a 19 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. | ||
| 533 | |f Annual Reviews Electronic Back Volume Collection 1932-2005ff | ||
| 700 | 1 | |a Lee, Agnes Y. Y. |4 oth | |
| 700 | 1 | |a Hirsh, Jack |4 oth | |
| 773 | 0 | 8 | |i in |t Annual review of medicine |d Palo Alto, Calif. : Annual Reviews, 1950 |g 53(2002), Seite 15-33 |h Online-Ressource |w (DE-627)NLEJ164018786 |w (DE-600)1481484-5 |x 1545-326X |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2002 |g pages:15-33 |g extent:19 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1146/annurev.med.53.082901.103957 |q text/html |z Deutschlandweit zugänglich |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-ANR | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2002 |h 15-33 |g 19 | ||
| matchkey_str |
article:1545326X:2002----::igoiadramnovnutr |
|---|---|
| hierarchy_sort_str |
2002 |
| publishDate |
2002 |
| allfields |
(DE-627)NLEJ164129421 DE-627 ger DE-627 rakwb DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM 2002 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. Annual Reviews Electronic Back Volume Collection 1932-2005ff Lee, Agnes Y. Y. oth Hirsh, Jack oth in Annual review of medicine Palo Alto, Calif. : Annual Reviews, 1950 53(2002), Seite 15-33 Online-Ressource (DE-627)NLEJ164018786 (DE-600)1481484-5 1545-326X nnns volume:53 year:2002 pages:15-33 extent:19 http://dx.doi.org/10.1146/annurev.med.53.082901.103957 text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-ANR GBV_NL_ARTICLE AR 53 2002 15-33 19 |
| spelling |
(DE-627)NLEJ164129421 DE-627 ger DE-627 rakwb DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM 2002 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. Annual Reviews Electronic Back Volume Collection 1932-2005ff Lee, Agnes Y. Y. oth Hirsh, Jack oth in Annual review of medicine Palo Alto, Calif. : Annual Reviews, 1950 53(2002), Seite 15-33 Online-Ressource (DE-627)NLEJ164018786 (DE-600)1481484-5 1545-326X nnns volume:53 year:2002 pages:15-33 extent:19 http://dx.doi.org/10.1146/annurev.med.53.082901.103957 text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-ANR GBV_NL_ARTICLE AR 53 2002 15-33 19 |
| allfields_unstemmed |
(DE-627)NLEJ164129421 DE-627 ger DE-627 rakwb DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM 2002 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. Annual Reviews Electronic Back Volume Collection 1932-2005ff Lee, Agnes Y. Y. oth Hirsh, Jack oth in Annual review of medicine Palo Alto, Calif. : Annual Reviews, 1950 53(2002), Seite 15-33 Online-Ressource (DE-627)NLEJ164018786 (DE-600)1481484-5 1545-326X nnns volume:53 year:2002 pages:15-33 extent:19 http://dx.doi.org/10.1146/annurev.med.53.082901.103957 text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-ANR GBV_NL_ARTICLE AR 53 2002 15-33 19 |
| allfieldsGer |
(DE-627)NLEJ164129421 DE-627 ger DE-627 rakwb DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM 2002 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. Annual Reviews Electronic Back Volume Collection 1932-2005ff Lee, Agnes Y. Y. oth Hirsh, Jack oth in Annual review of medicine Palo Alto, Calif. : Annual Reviews, 1950 53(2002), Seite 15-33 Online-Ressource (DE-627)NLEJ164018786 (DE-600)1481484-5 1545-326X nnns volume:53 year:2002 pages:15-33 extent:19 http://dx.doi.org/10.1146/annurev.med.53.082901.103957 text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-ANR GBV_NL_ARTICLE AR 53 2002 15-33 19 |
| allfieldsSound |
(DE-627)NLEJ164129421 DE-627 ger DE-627 rakwb DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM 2002 19 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. Annual Reviews Electronic Back Volume Collection 1932-2005ff Lee, Agnes Y. Y. oth Hirsh, Jack oth in Annual review of medicine Palo Alto, Calif. : Annual Reviews, 1950 53(2002), Seite 15-33 Online-Ressource (DE-627)NLEJ164018786 (DE-600)1481484-5 1545-326X nnns volume:53 year:2002 pages:15-33 extent:19 http://dx.doi.org/10.1146/annurev.med.53.082901.103957 text/html Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-ANR GBV_NL_ARTICLE AR 53 2002 15-33 19 |
| source |
in Annual review of medicine 53(2002), Seite 15-33 volume:53 year:2002 pages:15-33 extent:19 |
| sourceStr |
in Annual review of medicine 53(2002), Seite 15-33 volume:53 year:2002 pages:15-33 extent:19 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Annual review of medicine |
| authorswithroles_txt_mv |
Lee, Agnes Y. Y. @@oth@@ Hirsh, Jack @@oth@@ |
| publishDateDaySort_date |
2002-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ164018786 |
| id |
NLEJ164129421 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ164129421</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506101902.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070207s2002 xx |||||o 00| ||und c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ164129421</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">19</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Annual Reviews Electronic Back Volume Collection 1932-2005ff</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Agnes Y. Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hirsh, Jack</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Annual review of medicine</subfield><subfield code="d">Palo Alto, Calif. : Annual Reviews, 1950</subfield><subfield code="g">53(2002), Seite 15-33</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ164018786</subfield><subfield code="w">(DE-600)1481484-5</subfield><subfield code="x">1545-326X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:53</subfield><subfield code="g">year:2002</subfield><subfield code="g">pages:15-33</subfield><subfield code="g">extent:19</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1146/annurev.med.53.082901.103957</subfield><subfield code="q">text/html</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-ANR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">53</subfield><subfield code="j">2002</subfield><subfield code="h">15-33</subfield><subfield code="g">19</subfield></datafield></record></collection>
|
| series2 |
Annual Reviews Electronic Back Volume Collection 1932-2005ff |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ164018786 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| collection |
NL |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1545-326X |
| topic_title |
DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
a y y l ayy ayyl j h jh |
| hierarchy_parent_title |
Annual review of medicine |
| hierarchy_parent_id |
NLEJ164018786 |
| hierarchy_top_title |
Annual review of medicine |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ164018786 (DE-600)1481484-5 |
| title |
DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM |
| spellingShingle |
DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM |
| ctrlnum |
(DE-627)NLEJ164129421 |
| title_full |
DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM |
| journal |
Annual review of medicine |
| journalStr |
Annual review of medicine |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2002 |
| contenttype_str_mv |
zzz |
| container_start_page |
15 |
| container_volume |
53 |
| physical |
19 |
| format_se |
Elektronische Aufsätze |
| title_sort |
diagnosis and treatment of venous thromboembolism |
| title_auth |
DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM |
| abstract |
Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. |
| abstractGer |
Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. |
| abstract_unstemmed |
Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy. |
| collection_details |
GBV_USEFLAG_U ZDB-1-ANR GBV_NL_ARTICLE |
| title_short |
DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM |
| url |
http://dx.doi.org/10.1146/annurev.med.53.082901.103957 |
| remote_bool |
true |
| author2 |
Lee, Agnes Y. Y. Hirsh, Jack |
| author2Str |
Lee, Agnes Y. Y. Hirsh, Jack |
| ppnlink |
NLEJ164018786 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| up_date |
2024-07-06T10:11:15.769Z |
| _version_ |
1803824058356203520 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ164129421</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506101902.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070207s2002 xx |||||o 00| ||und c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ164129421</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">19</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Annual Reviews Electronic Back Volume Collection 1932-2005ff</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lee, Agnes Y. Y.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hirsh, Jack</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Annual review of medicine</subfield><subfield code="d">Palo Alto, Calif. : Annual Reviews, 1950</subfield><subfield code="g">53(2002), Seite 15-33</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ164018786</subfield><subfield code="w">(DE-600)1481484-5</subfield><subfield code="x">1545-326X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:53</subfield><subfield code="g">year:2002</subfield><subfield code="g">pages:15-33</subfield><subfield code="g">extent:19</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1146/annurev.med.53.082901.103957</subfield><subfield code="q">text/html</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-ANR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">53</subfield><subfield code="j">2002</subfield><subfield code="h">15-33</subfield><subfield code="g">19</subfield></datafield></record></collection>
|
| score |
7.4021664 |